Search Results

Filter
  • 1-10 of  14,718 results for ""CLINICAL trials""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023).

  • Authors : Li YN; Clinical Laboratory, The First Hospital of Jilin University, Changchun 130012, Jilin Province, China.; Xie B

Subjects: Immunotherapy* ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy; Humans

  • Source: World journal of gastroenterology [World J Gastroenterol] 2023 Oct 28; Vol. 29 (40), pp. 5593-5617.Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Beyond the Horizon: A Cutting-Edge Review of the Latest Checkpoint Inhibitors in Cancer Treatment.

  • Authors : Boutros M; Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.; Attieh F

Subjects: Immunotherapy* ; Melanoma*; Humans

  • Source: Cancer investigation [Cancer Invest] 2023 Oct; Vol. 41 (9), pp. 757-773. Date of Electronic Publication: 2023 Nov 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.

  • Authors : Pandey P; Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India.; Khan F

Subjects: Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/immunology ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2023 Sep; Vol. 1867 (9), pp. 130401. Date of Electronic Publication: 2023 Jun 10.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.

  • Authors : Hughes RT; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA.; Gebeyehu RR

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/epidemiology ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/therapy

  • Source: Future oncology (London, England) [Future Oncol] 2023 Jul; Vol. 19 (22), pp. 1523-1534. Date of Electronic Publication: 2023 May 18.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Geographic disparities in access to immunotherapy clinical trials for metastatic melanoma.

  • Authors : Mulligan KM; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. .; Zheng DX

Subjects: Immunotherapy* ; Melanoma*/Melanoma*/Melanoma*/therapy ; Healthcare Disparities*

  • Source: Archives of dermatological research [Arch Dermatol Res] 2023 May; Vol. 315 (4), pp. 1033-1036. Date of Electronic Publication: 2022 Oct 28.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).

  • Authors : Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA .; Abu-Sbeih H

Subjects: Clinical Trials as Topic* ; Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Sep; Vol. 10 (9).Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome.

  • Authors : Creemers JHA; Medical BioSciences, Radboud university medical center, Nijmegen, The Netherlands.; Oncode Institute, Nijmegen, The Netherlands.

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: Nature communications [Nat Commun] 2023 Apr 24; Vol. 14 (1), pp. 2348. Date of Electronic Publication: 2023 Apr 24.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immune checkpoint therapy-current perspectives and future directions.

  • Authors : Sharma P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

  • Source: Cell [Cell] 2023 Apr 13; Vol. 186 (8), pp. 1652-1669.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172

Record details

×
Academic Journal

Immunotherapy trials in Parkinson's disease: challenges.

  • Authors : Xiao B; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.; Tan EK

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy ; Immunotherapy*; Humans

  • Source: Journal of translational medicine [J Transl Med] 2023 Mar 06; Vol. 21 (1), pp. 178. Date of Electronic Publication: 2023 Mar 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Report

Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trials.

  • Authors : Bouche G; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom; The Anticancer Fund, Meise, Belgium. Electronic address: .

Subjects: Immune Checkpoint Inhibitors* ; Immunotherapy*; Humans

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jan; Vol. 178, pp. 88-90. Date of Electronic Publication: 2022 Oct 31.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  14,718 results for ""CLINICAL trials""